Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 975 of 2228 entries
View as:

Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01276288 Org: User:
Start: 01/31/11 End: - Due: -

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT00389207 Org: User:
Start: 10/31/06 End: - Due: -

A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05856526 Org: User:
Start: 06/12/23 End: 07/24/25 Due: 07/24/26

Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus

Phase: N/A Priority: Normal
NCT ID: NCT02238236 Org: User:
Start: 05/31/05 End: - Due: -

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BI 1744 CL in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171806 Org: User:
Start: 01/31/06 End: - Due: -

This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain

Phase: N/A Priority: Normal
NCT ID: NCT03993119 Org: User:
Start: 07/30/19 End: 08/20/20 Due: 08/20/21

BI 695500 vs Rituxan First Line Treatment in Patients With Low Tumor Burden Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02417129 Org: User:
Start: 04/30/15 End: 12/31/15 Due: 12/31/16

A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01040728 Org: User:
Start: 01/31/10 End: - Due: -

Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01012037 Org: User:
Start: 11/30/09 End: - Due: -

Safety, Tolerance, and Pharmacokinetics of BILN 2061 ZW in Healthy Male Subjects, Combined With Preliminary Evaluation of Food Effect

Phase: N/A Priority: Normal
NCT ID: NCT02268760 Org: User:
Start: 06/30/01 End: - Due: -

A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225

Phase: N/A Priority: Normal
NCT ID: NCT04065295 Org: User:
Start: 09/09/19 End: 12/23/19 Due: 12/23/20

Bioavailability of BI 144807 Given Alone and in Combination With Ketoconazole in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01707940 Org: User:
Start: 10/31/12 End: 12/31/12 Due: 12/31/13

A Multiple Increasing Dose Safety and Tolerability Study After Inhalation Administration of BIIX 1 XX in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02198313 Org: User:
Start: 04/30/99 End: - Due: -

Pharmacokinetics and Safety in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02045979 Org: User:
Start: 01/31/14 End: 06/20/14 Due: 06/20/15

Nonivamide/Nicoboxil Ointment in Acute Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT01708915 Org: User:
Start: 10/31/12 End: 04/30/13 Due: 04/30/14

Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)

Phase: N/A Priority: Normal
NCT ID: NCT02171156 Org: User:
Start: - End: - Due: -

Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of Afatinib

Phase: N/A Priority: Normal
NCT ID: NCT01298063 Org: User:
Start: 02/28/11 End: - Due: -

BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02209753 Org: User:
Start: 06/30/01 End: - Due: -

Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01090011 Org: User:
Start: 03/31/10 End: 08/31/14 Due: 08/31/15

Investigation of Potential Drug-drug Interaction of Volasertib With Itraconazole in Patients With Various Tumours

Phase: N/A Priority: Normal
NCT ID: NCT01772563 Org: User:
Start: 02/04/13 End: 04/22/21 Due: 04/22/22

Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity

Phase: N/A Priority: Normal
NCT ID: NCT02259751 Org: User:
Start: 02/29/04 End: - Due: -

Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa

Phase: N/A Priority: Normal
NCT ID: NCT02149303 Org: User:
Start: 06/30/14 End: 03/31/15 Due: 03/31/16

Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns

Phase: N/A Priority: Normal
NCT ID: NCT02138097 Org: User:
Start: 05/31/14 End: 08/31/14 Due: 08/31/15

Evaluation of Potential Off-label Use of Dabigatran Etexilate in Europe

Phase: N/A Priority: Normal
NCT ID: NCT02240654 Org: User:
Start: 11/28/14 End: 05/20/16 Due: 05/20/17

An International Observational Study of the Safety and Efficacy of Thrombolysis in Stroke

Phase: N/A Priority: Normal
NCT ID: NCT02229890 Org: User:
Start: 06/30/06 End: - Due: -